Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
East Afr Med J ; 90(2): 45-51, 2013 Feb.
Article in English | MEDLINE | ID: mdl-26866101

ABSTRACT

OBJECTIVE: The aim was to determine relative frequencies of acute leukemia immunophenotypes using commonly expressed markers and to describe the clinicopathological characteristics. Design: This was a prospective cross-sectional study. SETTING: The study was based at Aga khan clinical laboratory department. SUBJECTS: One hundred and thirty two (132) consecutive blood and bone marrow specimens from patients suspected to have acute leukemia were analysed for cytomorphological characteristics and immunophenotyping. The clinical-pathological characteristics were also recorded. Immunological category was assigned using the EGIL criteria. RESULTS: There were 88 AML and 42 ALL patients analysed for immunophenotypes. Only tw cases of biphenotypic leukemia were found. The commonest overall AML morphological sub-type was AML-M2, 26 (29.5%). Majority of ALL cases were B-cell immunological sub-type (96.6%). Early pre-B phenotype constituted 62.07% and Common B-cell ALL 37.93%. There were only 4 cases of T-cell ALL. Majority of patients presented with anaemia with a median hemoglobin of 7.5g/dl (range 2-15g/dl). The median platelet count was 55 (range 4-462 x 10(9)/L). CONCLUSION: Immunophenotyping of acute leukemia is beneficial in accurate diagnosis of patients with these malignancies in this setup. T-cell ALL, AML-M6 and M7 are less frequent than what has been reported in most studies in Africa.


Subject(s)
Immunophenotyping , Leukemia, Biphenotypic, Acute , Leukemia, Myeloid, Acute , Adolescent , Adult , Aged , Blood Cell Count/methods , Bone Marrow Examination/methods , Bone Marrow Examination/statistics & numerical data , Child , Flow Cytometry/methods , Hemoglobins/analysis , Humans , Immunophenotyping/methods , Immunophenotyping/statistics & numerical data , Kenya/epidemiology , Leukemia, Biphenotypic, Acute/blood , Leukemia, Biphenotypic, Acute/diagnosis , Leukemia, Biphenotypic, Acute/epidemiology , Leukemia, Myeloid, Acute/blood , Leukemia, Myeloid, Acute/diagnosis , Leukemia, Myeloid, Acute/epidemiology , Male , Middle Aged , Reproducibility of Results
2.
Clin Microbiol Infect ; 14(8): 755-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18727799

ABSTRACT

This study was designed to characterize the beta-lactamase content of carbapenem-resistant Pseudomonas aeruginosa isolates recovered during 2006 and 2007 in a large tertiary-care centre in Nairobi, Kenya. Molecular characterization was done using PCR and sequencing, and typing was performed using pulsed-field gel electrophoresis (PFGE). In total, 416 P. aeruginosa isolates were obtained during that period, of which 57 (13.7%) were resistant to carbapenems. All carbapenem-resistant isolates tested positive for metallo-beta-lactamase (MBL) production. All MBL isolates produced VIM-2 with two types of integron structures. PFGE identified three clonally related groups of VIM-2-producing P. aeruginosa, including a pan-resistant clone that was responsible for nosocomial outbreaks during 2006 and 2007 in the intensive-care unit. These findings suggest that continuous molecular surveillance needs to be performed to monitor the spread within the hospital of this pan-resistant strain. This study is the first report of VIM-2-producing P. aeruginosa from the African continent.


Subject(s)
Hospitals, University , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , beta-Lactamases/biosynthesis , Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Electrophoresis, Gel, Pulsed-Field , Humans , Integrons/genetics , Kenya/epidemiology , Microbial Sensitivity Tests , Polymerase Chain Reaction , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/enzymology , Pseudomonas aeruginosa/genetics , Sequence Analysis, DNA , beta-Lactam Resistance/genetics , beta-Lactamases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...